CLARITY PHARMA LTD
Get an alert when CLARITY PHARMA LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-07-31 (in 2mo)
Last filed for 2024-10-31
Confirmation statement due
2026-11-11 (in 6mo)
Last made up 2025-10-28
Watchouts
Cash
£24K
-35.1% lowest in 5 filed years
Net assets
-£809K
-410% lowest in 5 filed years
Employees
81
+47.3% highest in 5 filed years
Profit before tax
-£1M
-2,588.4% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
We draw attention to note 2.3 in the financial statements, which indicates that the company suffered a loss in the year ended 31 October 2024 and had net liabilities in the Balance Sheet of the same date. As stated in note 2.3, these events or conditions, along with the other matters as set forth in note 2.3, indicate that a material uncertainty exists that may cast significant doubt on the Company's ability to continue as a going concern.
Net assets
7-year trend · vs Consumer Discretionary median
Accounts
7-year trend · latest reflected 2024-10-31
| Metric | Trend | 2019-11-01 | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2022-11-01 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | £97,050,000 | £37,036,000 | £26,103,000 | — | £21,568,000 | £35,483,000 | |
| Operating profit | — | £502,000 | -£4,536,000 | -£628,000 | — | £371,000 | -£493,000 | |
| Profit before tax | — | £403,000 | -£4,664,000 | -£705,000 | — | £43,000 | -£1,070,000 | |
| Net profit | — | £303,000 | — | — | — | £334,000 | -£1,070,000 | |
| Cash | — | £334,000 | £1,953,000 | £94,000 | — | £37,000 | £24,000 | |
| Total assets less current liabilities | — | £5,450,000 | £1,441,000 | £633,000 | — | £751,000 | -£508,000 | |
| Net assets | — | £5,092,000 | £634,000 | -£73,000 | — | £261,000 | -£809,000 | |
| Equity | £5,189,000 | £5,092,000 | £634,000 | -£73,000 | — | £261,000 | -£809,000 | |
| Average employees | — | 24 | 27 | 30 | — | 55 | 81 | |
| Wages | — | £1,265,000 | £1,632,000 | £1,089,000 | — | £2,387,000 | £3,150,000 | |
| Directors' remuneration | — | £475,000 | £621,000 | £46,000 | — | £132,000 | £344,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-10-31 vs 2023-10-31
-
Turnover
+64.5%
£21,568,000 £35,483,000
-
Cash
-35.1%
£37,000 £24,000
lowest in 5 filed years
-
Net assets
-410%
£261,000 -£809,000
lowest in 5 filed years
-
Employees
+47.3%
55 81
highest in 5 filed years
-
Operating profit
-232.9%
£371,000 -£493,000
-
Profit before tax
-2,588.4%
£43,000 -£1,070,000
-
Wages
+32%
£2,387,000 £3,150,000
highest in 5 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-11-01 | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2022-11-01 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | 0.5% | -12.2% | -2.4% | — | 1.7% | -1.4% | |
| Net margin | — | 0.3% | — | — | — | 1.5% | -3.0% | |
| Return on capital employed | — | 9.2% | -314.8% | -99.2% | — | 49.4% | 97.0% | |
| Current ratio | — | — | — | — | — | 1.04x | 0.93x | |
| Interest cover | — | 4.87x | -35.44x | -8.16x | — | 1.13x | -0.85x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- CLARITY PHARMA LTD 2011-01-20 → present
- UNIQUE SOLUTIONS FOR PHARMA LIMITED 2006-06-20 → 2011-01-20
- A D L HEALTHCARE LTD. 2000-05-08 → 2006-06-20
- A D L CONSULTING LTD. 1998-10-28 → 2000-05-08
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Price Bailey LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 2.3 in the financial statements, which indicates that the company suffered a loss in the year ended 31 October 2024 and had net liabilities in the Balance Sheet of the same date. As stated in note 2.3, these events or conditions, along with the other matters as set forth in note 2.3, indicate that a material uncertainty exists that may cast significant doubt on the Company's ability to continue as a going concern.”
Significant events
- “There have been no significant events affecting the Company since the year end.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MADDISON, Keith | Director | 2021-08-25 | Jul 1959 | British |
| MADDISON, Margo | Director | 2023-04-25 | Sep 1971 | British |
| SOPER, Steven Alan | Director | 2023-07-07 | Jan 1973 | British |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FISHER, Robert Henry | Secretary | 2021-02-03 | 2021-07-16 |
| GREEN, Andrew | Secretary | 2011-03-14 | 2021-02-03 |
| LEAVER, Linda | Secretary | 1998-10-28 | 2006-05-31 |
| SCOTT, Margo | Secretary | 2006-05-31 | 2011-03-14 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1998-10-28 | 1998-10-28 |
| CRESSWELL, Mark | Director | 2002-01-21 | 2003-10-01 |
| DORLING, Alan Robert | Director | 2008-06-30 | 2009-01-01 |
| ELFORD, Craig Lewis | Director | 2003-10-01 | 2005-04-01 |
| FISHER, Robert Henry | Director | 2020-12-21 | 2021-07-16 |
| GREEN, Andrew | Director | 2020-04-22 | 2021-02-03 |
| HANSON, John Jeffrey | Director | 2020-12-21 | 2021-07-02 |
| LAW, Oliver James | Director | 2021-01-07 | 2021-10-29 |
| LEAVER, Andrew Derrick | Director | 1998-10-28 | 2006-05-31 |
| LEAVER, Linda | Director | 2001-06-01 | 2005-11-01 |
| MADDISON, Keith | Director | 2001-06-01 | 2011-03-14 |
| MAGINLEY, Raymond Bronson | Director | 2002-01-08 | 2003-10-01 |
| MATTHEWS, Yvonne Sandra | Director | 2005-04-01 | 2005-11-23 |
| MICHAEL, Gregory Morris | Director | 2008-05-22 | 2009-01-01 |
| MONTEITH, Tanya | Director | 2011-01-12 | 2020-04-22 |
| PYLE, Zoe | Director | 2021-11-01 | 2022-01-26 |
| RAPHAEL, Marcus John | Director | 2020-10-01 | 2020-11-20 |
| RICHARDS, Emily Elizabeth | Director | 2020-10-01 | 2020-12-21 |
| SCOTT, Margo | Director | 2008-05-22 | 2011-03-14 |
| SIBSON, Robin Andrew John | Director | 2005-04-01 | 2006-05-31 |
| UPTON, Matthew | Director | 2011-01-12 | 2012-10-31 |
| K&M MADDISON INTERNACIONAL SL | Corporate Director | 2011-03-14 | 2023-04-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Clarity Global Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-10-28 | Active |
Filing timeline
Last 20 of 178 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-10 | AA | accounts | Accounts with accounts type full | |
| 2025-11-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-02 | AR01 | annual-return | Annual return company with made up date full list shareholders | |
| 2024-04-04 | AR01 | annual-return | Annual return company with made up date full list shareholders | |
| 2024-02-28 | AA | accounts | Accounts with accounts type full | |
| 2024-01-25 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-01-25 | PSC05 | persons-with-significant-control | Change to a person with significant control without name date | |
| 2023-11-02 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-07-07 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-26 | CH01 | officers | Change person director company with change date | |
| 2023-04-26 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-20 | CH02 | officers | Change corporate director company with change date | |
| 2023-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-02-10 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-02-10 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-11-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-31 | AA | accounts | Accounts with accounts type full | |
| 2022-10-17 | MR04 | mortgage | Mortgage satisfy charge full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.